Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Agilent and Stemina partner in metabolomic research effort
July 2010
SHARING OPTIONS:

SANTA CLARA, Calif.Agilent Technologies Inc. and Stemina Biomarker Discovery Inc. recently announced a partnership agreement to accelerate Stemina's metobolomic research. Stemina uses metabolomic analysis of stem cells for the discovery of biomarkers for use in drug screening and drug development. Agilent will provide a 1290 Infinity UHPLC system to separate stem cellular metabolites, coupled to a 6530 Accurate Mass quadrupole time-of-flight mass spectrometer to identify those metabolites. Agilent will also provide Mass Profiler Professional software to help Stemina researchers interpret the complex data generated by metabolomics experiments. 

"Metabolomics is a major growth area for us, and the innovative work being done at Stemina is the kind we like to support," says Gustavo Salem, vice president and general manager of Agilent's Biological Systems division.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.